HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Review of 36 studies: GLP-1 weight loss is mostly fat, with modest lean mass loss

Louis Nervegna · May 15, 2026 · ♥ 7 reactions · 3 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Weight, visceral & liver fatExercise & fitness
AI summary & key facts

Louis shares an International Journal of Obesity meta-analysis of GLP-1 and dual GLP-1/GIP drugs in adults with overweight or obesity. Most weight lost was fat, including visceral fat, and muscle loss was no worse than with calorie restriction, though protein and resistance training still matter.

The muscle loss is no worse than calorie restriction diets.

Link to full study:

Paper · Int J Obes · 2026GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysisnature.com

#glp1HD #weightlossHD #muscleHD

Research cited

💉 GLP-1 weight-loss drugs may not cause as much muscle loss as many feared.

A new systematic review analyzed 36 studies on GLP-1 receptor agonists and dual GLP-1/GIP drugs in adults with overweight or obesity, with or without type 2 diabetes.

The overall pattern was reassuring: most of the weight lost came from fat, including visceral fat around the organs. Lean body mass did decline in some people, but the loss was generally modest compared with the reduction in fat mass.

That does not mean muscle loss is impossible or unimportant. Lean mass can include muscle, water, organs, and other tissues, so body-composition results need careful interpretation.

The practical message is balance: GLP-1 drugs may support “higher-quality” weight loss, but protein intake, resistance training, and medical supervision still matter for protecting strength and long-term health.

📃 RESEARCH PAPER
📌 Sawicka-Gutaj et al., “GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis”, International Journal of Obesity (2026)

No photo description available.
← newer: A 10-day high-polyphenol olive oil protocol anecdote cites Polder: A pea, black bean and chickpea protein powder avoids insulin →